SEC Filing Details

Document Details

Form
Filing Date
Aug 12, 2021
Document Date
Aug 10, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.
Filer
Martin Samuel Bates

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline